Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013

BMC Oral Health

Volumn 14, Issue 1, 2014, Pages

  Kamikawa, Yoshiaki ^a   Mori, Youichirou ^b   Nagayama, Tomohiro ^b   Fujisaki, Junichi ^b   Hirabayashi, Daisuke ^b   Sakamoto, Ryoichi ^b   Hamada, Tomofumi ^b   Sugihara, Kazumasa ^a,b  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Candida albicans; Candida glabrata; Clinically isolated strains; Minimal inhibitory concentration; Resistant strains

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; LIPOPEPTIDE; MICAFUNGIN; MICONAZOLE;

ADULT; AGED; ANTIFUNGAL RESISTANCE; AUTOIMMUNE DISEASE; BACTERIAL LOAD; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, ORAL; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; JAPAN; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MIXED INFECTION; VERY ELDERLY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; AUTOIMMUNE DISEASES; BACTERIAL LOAD; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, ORAL; COINFECTION; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FEMALE; FLUCONAZOLE; FLUCYTOSINE; HUMANS; ITRACONAZOLE; JAPAN; LIPOPEPTIDES; MALE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; XEROSTOMIA;

EID: 84894337244     PISSN: None     EISSN: 14726831     Source Type: Journal    
DOI: 10.1186/1472-6831-14-14     Document Type: Article

References (31)

1. Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA. International surveillance of blood stream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and south america for the SENTRY program. The SENTRY participant group. J Clin Microbiol 1997, 36:1886-1889.
2. Messer SA, Moet GJ, Kirby JT, Jones RN. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and aspergillus spp.: report from the SENTRY antimicrobial surveillance program (2006 to 2007). J Clin Microbiol 2009, 47:1942-1946. 10.1128/JCM.02434-08, 2691076, 19386851.
3. Villanueva A, Arathoon EG, Gotuzzo E, Berman RS, DiNubile MJ, Sable CA. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. Clin Infect Dis 2001, 33:1529-1535. 10.1086/323401, 11588698.
4. Villanueva A, Gotuzzo E, Arathoon EG, Noriega LM, Kartsonis NA, Lupinacci RJ, Smietana JM, DiNubile MJ, Sable CA. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med 2002, 113:294-299. 10.1016/S0002-9343(02)01191-9, 12361815.
5. de Wet N, Llanos-Cuentas A, Suleiman J, Baraldi E, Krantz EF, Della Negra M, Diekmann-Berndt H. A randomized, double blind, parallel group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV positive patients. Clin Infect Dis 2004, 39:842-8499. 10.1086/423377, 15472817.
6. Krause DS, Simjee AE, van Rensburg C, Viljoen J, Walsh TJ, Goldstein BP, Aible M, Henkel T. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clin Infect Dis 2004, 39:770-775. 10.1086/423378, 15472806.
7. Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S, the Japan invasive mycosis surveillance study group National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 2004, 53:283-289. 10.1093/jac/dkh053, 14688039, the Japan invasive mycosis surveillance study group.
8. Yamaguchi H, Uchida K, Okuzumi K, Oguri T, Adachi K, Kawakami S, Tosaka M, Kawashima C, Hori Y, Kitazawa T, Hayamshi M, Saito Y, Ozaki K, Nishiyama Y. Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan antifungal surveillance program (JASP), 2001-2002. J Jpn Soc Clin Microbiol 2004, 14:183-193.
9. Yamaguchi H, Uchida K, Nishiyama Y, Okuizumi K, Oguri T, Adachi K, Kawakami S, Tosaka M, Misawa Y, Kawashima C, Hori Y, Kitazawa T, Hayashi M, Okimura Y. Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan antifungal surveillance program (JASP), 2003. J Jpn Soc Clin Microbiol 2006, 16:13-22.
10. Yamaguchi H, Nishiyama Y, Uchida K, Takahashi C, Kawashima C, Hayashi M, Kawakami S, Adachi K, Okuizumi K, Misawa Y, Oguri T, Okimura Y, Kitazawa T, Hori Y, Tosaka M. Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan antifungal surveillance program (JASP), 2005. J Jpn Soc Clin Microbiol 2009, 19:128-141.
11. Kamikawa Y, Nagayama T, Fujisaki J, Hirabayashi D, Kawasaki K, Hamada T, Mori Y, Kamikawa Y, Mukai H, Sato T, Sugihara K. Clinical study on anti-fungal drug activity against clinically isolated strains of oral Candida species. Oral Sci Int 2013, 10:87-94.
12. Sudo T, Makimura K, Kawata K, Ito A, Oka S, Uchida K, Yamaguchi H. Evaluation of antifungal susceptibility testing by the broth micro dilution method against Candida species: activities of 5 antifungal agents against Candida species isolated from oral candidiasis or other candidal infectious diseases and correlation of vitro data and clinical outcome of fluconazole therapy. Jpn J Chemotherapy 1997, 45:115-122.
13. Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast 2002, 19:973-989. 10.1002/yea.892, 12125054.
14. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis 2009, 48:503-535. 10.1086/596757, 19191635.
15. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-third edition M27-A3 2008, Wayne PA USA: CLSI, Clinical and Laboratory Standards Institute.
16. Yamaguchi H. Anti-fungal drug sensitivity test. Modern media 2009, 55:309-320.
17. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol 2013, 51:841-848. 10.1128/JCM.02566-12, 3592045, 23269738.
18. de Almeida AA, Mesquita CSS, Svidzinski TIES, de Oliveira KMP. Antifungal susceptibility and distribution of Candida spp. Isolates from the university hospital in the municipality of Dourados, state of Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop 2013, 46:335-339. 10.1590/0037-8682-0074-2012, 23856873.
19. De luca C, Guglielminetti M, Ferrario A, Calabro M, Casari E. Candidemia: species involved, virulence factors and antimycotic susceptibility. New Microbiol 2012, 35:459-468.
20. Santhanam J, Yahaya N, Aziz MN. Species distribution and antifungal susceptibility patters of Candida species: is low susceptibility to itaconazole a trend in Malaysia?. Med J Mlaysia 2013, 68:343-347.
21. Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D. Epidemiology and outcomes of candidemia in 3648 patients: data from the prospective antifungal therapy (PATH alliance®) registry, 2004-2008. Diagn Microbiol Infect Dis 2012, 74:323-331. 10.1016/j.diagmicrobio.2012.10.003, 23102556.
22. Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, Schreiber AZ. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol 2013, 51:225-230. 10.3109/13693786.2012.708107, 22920712.
23. Zhang XB, Yu SJ, Yu JX, Gong YL, Feng W, Sun FJ. Retrospective analysis of epidemiology and prognostic factors for candidemia at a hospital in China, 2000-2009. Jpn J Infect Dis 2012, 65:510-515. 10.7883/yoken.65.510, 23183203.
24. Hoegl L, Thoma-Greber E, Röcken M, Korting HC. Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency cirus-infected patient observed over a period of 6 years. Mycoses 1998, 41:335-338. 10.1111/j.1439-0507.1998.tb00347.x, 9861840.
25. Redding SW, Kirkpatrick WR, Coco BJ, Sadkowski L, Fothergill AW, Rinaldi MG, Eng TY, Patterson TF. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Micribiol 2002, 40:1879-1881.
26. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002, 35:627-630. 10.1086/342300, 12173140.
27. Nguyen MH, Peacock JE, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996, 100:617-623. 10.1016/S0002-9343(95)00010-0, 8678081.
28. Pfaller AM, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program. Diag Microbiol Infect Dis 1998, 30:121-129.
29. Silva S, Henriques M, Hayes A, Oliveira R, Azeredo J. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. Oral Pathol Med 2011, 40:421-427.
30. Meurman JH, Siikala E, Richardson M, Rauteman R. Non-Candia albicans Candida yeasts of the oral cavity. Communicating current research and educational topics and trends in applied microbiology 2007, 719-731. Madrid: Formatex.
31. Sanita PV, de Oliveira Mima EG, Pavarina AC, Jorge JH, Machando AL, Vergani CE. Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated form subjects with Candida-associated denture stomatitis with or without diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol 2013, 116:562-569. 10.1016/j.oooo.2013.07.002, 24055150.